2020-04-08T10:51:47-05:00 2019-12-31 BDO USA LLP 8401 GREENSBORO DRIVE 800 MCLEAN VA 22102 990 2019-01-01 522044704 AERAS % DONNA D'AMATO AERA 3015472900 PO Box 2352 Germantown MD 20875 JENNIFER WELGOS CFO 3015472900 2020-04-03 true Jacob Cook P01240455 7038930600 173.79.216.230 54621820200995000024 2020-04-08 P 651D255A1A915A1FDEE8CC96D476D00223E3EE33 651D255A1A915A1FDEE8CC96D476D00223E3EE33 2019 2021-01-29 14:40:06Z JACQUELINE SHEA LUCAS PO BOX 20875 Germantown MD 20875 2610423 false X WWW.AERAS.ORG X 1997 DC DEDICATED TO THE DEVELOPMENT OF EFFECTIVE TUBERCULOSIS (TB) VACCINES & BIOLOGICS TO PREVENT TB ACROSS ALL AGE GROUPS IN AN AFFORDABLE & SUSTAINABLE MANNER. 2 1 11 1 0 11642334 805210 50007 0 19958 68789 -59363 0 11652936 873999 3990465 0 0 0 7880320 834358 0 0 0 12299157 1089105 24169942 1923463 -12517006 -1049464 6701003 3261871 1940459 31226 4760544 3230645 X AERAS IS A NON-PROFIT PRODUCT DEVELOPMENT ORGANIZATION DEDICATED TO THE DEVELOPMENT OF EFFECTIVE TUBERCULOSIS (TB) VACCINES AND BIOLOGICS TO PREVENT TB ACROSS ALL AGE GROUPS IN AN AFFORDABLE AND SUSTAINABLE MANNER. AERAS UTILIZES ITS BROAD CAPABILITIES AND TECHNOLOGIES IN COLLABORATION WITH NUMEROUS PARTNERS AND STAKEHOLDERS TO SUPPORT THE DEVELOPMENT OF VACCINES AND OTHER BIOPHARMACEUTICALS TO ADDRESS TB AND OTHER SIGNIFICANT PUBLIC HEALTH NEEDS OF UNDERSERVED POPULATIONS. IN THE PURSUIT OF OUR MISSION, WE ARE GUIDED BY OUR CORE VALUES. THESE CORE VALUES EXPRESS OUR ASPIRATIONS AND THE BEHAVIORS WE WANT TO EXHIBIT AND MODEL. THEY SHAPE THE CULTURE AND CHARACTER OF AERAS AND INFORM ALL OF OUR DECISIONS AND ACTIONS. false true 77352 0 0 SUPPORT TO PRECLINICAL, CLINICAL AND RESEARCH EFFORTS TO HELP RAISE AWARENESS AND SUPPORT TB VACCINES. 77352 true true false false false false false false false false false false false true false false false false false true true false false false false false false false false true false false false false false false false false false false false false false true true true false false true 24 0 true 11 true false true HK false false false false false false false false false false X 2 1 false false false false false false false true true false false true true true true true true true true false MD X X DONNA D'AMATO 3015472923 PO BOX 2352 Germantown MD 20875 JACQUELINE SHEA CEO 0.0 0.0 X 498455 0 0 DONNA D'AMATO CONTROLLER 40.0 0.0 X 261688 0 1320 JACQUELINE SHEPPARD ASSOC DIR, PAYROLL & BENEFITS 40.0 0.0 X 250743 0 11265 MARIA RUIZ SR. MANAGER, EHS 40.0 0.0 X 123968 0 982 BRANDON LAU DIRECTOR, FP&A 0.0 0.0 X 108289 0 0 JENNIFER WELGOS INTERIM CEO 10.0 0.0 X 72091 0 0 DAVID BLUMBERG DIRECTOR 1.0 0.0 X 0 0 0 1315234 0 13567 5 false true false BDO USA LLP 8401 GREENSBORO DRIVE MCLEAN VA 22102 ACCOUNTING SERVICES 164743 1 800000 5210 805210 0 54887 54887 0 0 0 0 0 1750326 1736424 13902 13902 13902 0 0 0 0 0 0 0 0 0 0 873999 68789 0 0 0 0 570546 570546 0 0 0 124215 124215 0 0 0 63717 63717 0 75880 75880 0 0 0 64488 64488 0 273473 273473 0 0 0 0 0 0 0 0 0 0 76041 3858 72183 0 0 0 0 0 109139 109139 0 6995 6995 0 0 0 1967 130 1837 0 0 0 0 0 0 0 308779 308779 0 CONTRACT SERVICES 248223 73364 174859 0 1923463 77352 1846111 0 500 0 1491163 2804399 0 0 878951 13562 0 0 0 0 0 0 0 0 236030 0 0 0 318 0 3528734 0 0 0 0 0 0 0 565307 443910 6701003 3261871 1940459 31226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1940459 31226 X 1541571 1541571 3218973 1689074 4760544 3230645 6701003 3261871 X -1049464 -480435 X false false false X ST LOUIS ST LOUIS MO OREGON HEALTH PORTLAND OR ALBERT EINSTEIN COLLEGE OF MEDICINE NEW YORK NY UNIVERSITY OF PITTSBURGH PITTSBURG PA VACCINE RESEARCH CENTER AT NIH BETHESDA MD RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED DUE FROM RELATED ENTITIES 108602 INVESTMENT IN RELATED PARTIES 335308 443910 East Asia and the Pacific 0 0 Program Services TB VACCINE SUPPORT 11248 0 0 0 0 11248 11248 false false true false false false X X X X X true false false false false false false false false JACQUELINE SHEA CEO 56057 0 236001 0 206397 0 0 0 0 0 498455 0 0 0 DONNA D'AMATO CONTROLLER 115560 0 98290 0 47838 0 0 0 1320 0 263008 0 0 0 JACQUELINE SHEPPARD ASSOC DIR, PAYROLL & BENEFITS 88528 0 103903 0 58312 0 0 0 11265 0 262008 0 0 0 SCHEDULE J, PART I, LINE 4A Due to the lack of funding and the ultimate decision to close Aeras, all employees were offered a severance package. JACQUELINE SHEA RECEIVED $206,397 OF SEVERANCE. DONNA D'AMATO RECEIVED $47,838 OF SEVERANCE. JACQUELINE SHEPPARD RECEIVED $8,312 OF SEVERANCE. MARIA RUIZ RECEIVED $65,246 OF SEVERANCE. BRANDON LAU RECEIVED $62,916 OF SEVERANCE. FORM 990, PART III, LINE 3: DURING 2019 THE ORGANIZATION CEASED CONDUCTING ALL PROGRAM SERVICE OPERATIONS. FORM 990, PART VI, LINE 11B A draft version of the Form 990 is shared with the Board of Directors of Aeras and once approved it is filed with the IRS. FORM 990, PART VI, LINE 12C Aeras' policy is written to protect Aeras' interest when it is contemplating entering into a transaction or arrangement that might benefit the private interest of directors, committee members, officers, employees and retained consultants of Aeras. In connection with any actual or possible conflicts of interest, an interested person must disclose the existence of his or her interest and all material facts to the directors and members of the committee with board-delegated powers considering the proposed transaction or arrangement. After disclosure of all material facts and discussion with the person, the person shall leave the board or committee meeting while their determination of a conflict of interest is discussed and voted upon. The remaining board or committee members shall decide if a conflict of interest exists. Disclosure of all material facts and discussion with the person, the person shall leave the board or committee meeting while their determination of a conflict of interest is discussed and voted upon. The remaining board or committee members shall decide if a conflict of interest exists. FORM 990, PART VI, LINE 15 Aeras has a Compensation Committee which determines the CEO compensation level based on her responsibilities, size of the organization, funding levels and organization objectives. Compensation is based on comparability data, is approved by independent Board members, and the process is documented in the Board minutes. Compensation for other officers is determined by the CEO, based on the officer's responsibilities, funding levels and organization objectives. compensation is based on comparability data and is shared with independent board members. FORM 990, PART VI, LINE 19 Governing documents, including Articles of Incorporation, Bylaws, Board minutes, Conflict of Interest policy and financial statements are available upon request. FORM 990, PART XI, LINE 9 OTHER CHANGES IN NET ASSETS FOR FUND BALANCES RETURN OF CONTRIBUTIONS ($480,435) AERAS HONG KONG UNIT 1618 16/F MIRAMAR TOWER KOWLOON HK Holding Company HK Aeras C Corp -2393 156502 1.00000 true Aeras Beijing Biological Tech Co Ltd Unit 1446 14F A Tower Pacific Beijing CH Consulting CH Aeras Hong Kong C Corp 0 0 0.00000 false false false false false false false false false false false false false false true true false false false false